Resultats de la cerca - William C. Dougall

Refinar resultats
  1. 1
    Targeting RANKL in metastasis

    Targeting RANKL in metastasis per William C. Dougall, Ingunn Holen, Eva González‐Suárez

    Publicat 2014
    Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  2. 2
    The Involvement of Multiple Tumor Necrosis Factor Receptor (TNFR)-associated Factors in the Signaling Mechanisms of Receptor Activator of NF-κB, a Member of the TNFR Superfamily

    The Involvement of Multiple Tumor Necrosis Factor Receptor (TNFR)-associated Factors in the Signaling Mechanisms of Receptor Activator of NF-κB, a Member of the TNFR Superfamily per Laurent Galibert, Mark Tometsko, Dirk Anderson, David Cosman, William C. Dougall

    Publicat 1998
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  3. 3
    Regulation of manganese superoxide dismutase by lipopolysaccharide, interleukin-1, and tumor necrosis factor. Role in the acute inflammatory response.

    Regulation of manganese superoxide dismutase by lipopolysaccharide, interleukin-1, and tumor necrosis factor. Role in the acute inflammatory response. per Gary Visner, William C. Dougall, James M. Wilson, Ian A. Burr, Harry S. Nick

    Publicat 1990
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  4. 4
    Ligand and p185c-neu density govern receptorinteractions and tyrosine kinase activation.

    Ligand and p185c-neu density govern receptorinteractions and tyrosine kinase activation. per Arabinda Samanta, Charles LeVea, William C. Dougall, Xiaolan Qian, M.I. Greene

    Publicat 1994
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  5. 5
    A RANK/TRAF6-dependent Signal Transduction Pathway Is Essential for Osteoclast Cytoskeletal Organization and Resorptive Function

    A RANK/TRAF6-dependent Signal Transduction Pathway Is Essential for Osteoclast Cytoskeletal Organization and Resorptive Function per Allison Armstrong, Mark Tometsko, Moira Glaccum, Claire L. Sutherland, David Cosman, William C. Dougall

    Publicat 2002
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  6. 6
    Heterodimerization of epidermal growth factor receptorand wild-type or kinase-deficient Neu: a mechanism of interreceptor kinaseactivation and transphosphorylation.

    Heterodimerization of epidermal growth factor receptorand wild-type or kinase-deficient Neu: a mechanism of interreceptor kinaseactivation and transphosphorylation. per Xiaolan Qian, Charles LeVea, J K Freeman, William C. Dougall, Mark I. Greene

    Publicat 1994
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  7. 7
    RANK Overexpression in Transgenic Mice with Mouse Mammary Tumor Virus Promoter-Controlled RANK Increases Proliferation and Impairs Alveolar Differentiation in the Mammary Epithelia and Disrupts Lumen Formation in Cultured Epithelial Acini

    RANK Overexpression in Transgenic Mice with Mouse Mammary Tumor Virus Promoter-Controlled RANK Increases Proliferation and Impairs Alveolar Differentiation in the Mammary Epithelia... per Eva González‐Suárez, Daniel Branstetter, Allison Armstrong, Huyen Dinh, Hal Blumberg, William C. Dougall

    Publicat 2006
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  8. 8
    RANKL acts directly on RANK‐expressing prostate tumor cells and mediates migration and expression of tumor metastasis genes

    RANKL acts directly on RANK‐expressing prostate tumor cells and mediates migration and expression of tumor metastasis genes per Allison Armstrong, Robert E. Miller, Jon C. Jones, Jian Zhang, Evan T. Keller, William C. Dougall

    Publicat 2007
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  9. 9
    RANK ligand inhibition plus docetaxel improves survival and reduces tumor burden in a murine model of prostate cancer bone metastasis

    RANK ligand inhibition plus docetaxel improves survival and reduces tumor burden in a murine model of prostate cancer bone metastasis per Robert E. Miller, Martine P. Roudier, Jon C. Jones, Allison Armstrong, Jude Canon, William C. Dougall

    Publicat 2008
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  10. 10
    Molecular Pathways: Targeting CD96 and TIGIT for Cancer Immunotherapy

    Molecular Pathways: Targeting CD96 and TIGIT for Cancer Immunotherapy per Stephen J. Blake, William C. Dougall, John J. Miles, Michele W.L. Teng, Mark J. Smyth

    Publicat 2016
    Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  11. 11
    RANK and RANK ligand expression in primary human osteosarcoma

    RANK and RANK ligand expression in primary human osteosarcoma per Daniel Branstetter, Kathy Rohrbach, Liya Huang, R Soriano, Mark Tometsko, Michelle Blake, Allison P. Jacob, William C. Dougall

    Publicat 2015
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  12. 12
    Constitutive activation of RANK disrupts mammary cell fate leading to tumorigenesis

    Constitutive activation of RANK disrupts mammary cell fate leading to tumorigenesis per Pasquale Pellegrini, Álex Cordero, Marta I. Gallego, William C. Dougall, Purificacı́on Muñoz, Miguel Ángel Pujana, Eva González‐Suárez

    Publicat 2013
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  13. 13
    Osteoclast Differentiation Is Impaired in the Absence of Inhibitor of κB Kinase α

    Osteoclast Differentiation Is Impaired in the Absence of Inhibitor of κB Kinase α per Michelle Chaisson, Daniel Branstetter, Jonathan M.J. Derry, Allison Armstrong, Mark Tometsko, Kiyoshi Takeda, Shizuo Akira, William C. Dougall

    Publicat 2004
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  14. 14
    The Novel Receptor TRAIL-R4 Induces NF-κB and Protects against TRAIL-Mediated Apoptosis, yet Retains an Incomplete Death Domain

    The Novel Receptor TRAIL-R4 Induces NF-κB and Protects against TRAIL-Mediated Apoptosis, yet Retains an Incomplete Death Domain per Mariapia A. Degli‐Esposti, William C. Dougall, Pamela J. Smolak, Jennifer Y. Waugh, Craig A. Smith, Raymond G. Goodwin

    Publicat 1997
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  15. 15
    RANKL blockade improves efficacy of PD1-PD-L1 blockade or dual PD1-PD-L1 and CTLA4 blockade in mouse models of cancer

    RANKL blockade improves efficacy of PD1-PD-L1 blockade or dual PD1-PD-L1 and CTLA4 blockade in mouse models of cancer per Elizabeth Ahern, Heidi Harjunpää, Jake S. O’Donnell, Stacey Allen, William C. Dougall, Michele W.L. Teng, Mark J. Smyth

    Publicat 2018
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  16. 16
    An observational study of concomitant immunotherapies and denosumab in patients with advanced melanoma or lung cancer

    An observational study of concomitant immunotherapies and denosumab in patients with advanced melanoma or lung cancer per Alexander Liede, Rohini K. Hernandez, Sally Wade, Ronghai Bo, Nathan C. Nussbaum, Elizabeth Ahern, William C. Dougall, Mark J. Smyth

    Publicat 2018
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  17. 17
    RANK-ligand (RANKL) expression in young breast cancer patients and during pregnancy

    RANK-ligand (RANKL) expression in young breast cancer patients and during pregnancy per Hatem A. Azim, Fedro A. Peccatori, Sylvain Brohée, Daniel Branstetter, Sherene Loi, Giuseppe Viale, Martine Piccart, William C. Dougall, Giancarlo Pruneri, Christos Sotiriou

    Publicat 2015
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  18. 18
    Co-administration of RANKL and CTLA4 Antibodies Enhances Lymphocyte-Mediated Antitumor Immunity in Mice

    Co-administration of RANKL and CTLA4 Antibodies Enhances Lymphocyte-Mediated Antitumor Immunity in Mice per Elizabeth Ahern, Heidi Harjunpää, Deborah S. Barkauskas, Stacey Allen, Kazuyoshi Takeda, Hideo Yagita∥, David Wyld, William C. Dougall, Michele W.L. Teng, Mark J. Smyth

    Publicat 2017
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  19. 19
    Effects of receptor activator of NFκB (RANK) signaling blockade on fracture healing

    Effects of receptor activator of NFκB (RANK) signaling blockade on fracture healing per Lisa M. Flick, Jason M. Weaver, Michael Ulrich‐Vinther, F.S. Abuzzahab, Xinping Zhang, William C. Dougall, Dirk Anderson, Regis J. O’Keefe, Edward M. Schwarz

    Publicat 2003
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  20. 20
    CD96 targeted antibodies need not block CD96-CD155 interactions to promote NK cell anti-metastatic activity

    CD96 targeted antibodies need not block CD96-CD155 interactions to promote NK cell anti-metastatic activity per Amelia Roman Aguilera, Viviana P. Lutzky, Deepak Mittal, Xian-Yang Li, Kimberley Stannard, Kazuyoshi Takeda, Günter Bernhardt, Michele W.L. Teng, William C. Dougall, Mark J. Smyth

    Publicat 2018
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:

Eines de cerca: